FDA Approves FoundationOne Liquid CDx Liquid Biopsy Test
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read More
Search Results for: lung cancer
Thermo Fisher, Hengrui Therapeutics to Develop CDx for NSCLC
The companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients with HER2 mutations.
Read More
Study Focuses on Different Kind of Liquid Biopsy to Detect Cancer
Researchers report EVPs, tiny packages of materials released by tumors, may serve as biomarkers for detecting different types of cancer with liquid biopsy.
Read More
FDA Approves First Liquid Biopsy NGS Companion Diagnostic
This is the first approval to combine two technologies—NGS and liquid biopsy—in one diagnostic in order to guide treatment decisions.
Read More
Liquid Biopsy Research Reveals New Insights on Genetic Changes in Cancer
Researchers used Menarini Silicon Biosystems’ liquid biopsy technology to learn more about genetic changes in circulating cancer cells.
Read More